Glaxosmithkline (GSK)

 

GSK Share PerformanceMore

52 week high1,724.5 22/06/17
52 week low1,270.0 06/12/17
52 week change -198.0 (-12.78%)
4 week volume189,801,643 23/12/17

Latest NewsMore

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

Liberum Capital today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target t...

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

Barclays Capital today upgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to overweight (from equal we...

Director/PDMR Shareholding

RNS Number: 0616C GlaxoSmithKline PLC 16 January 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participa...

Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLC

Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and set its price tar...

Broker Forecast - Exane BNP Paribas issues a broker note on GlaxoSmithKline PLC

Exane BNP Paribas today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and set its price ta...

Director/PDMR Shareholding

RNS Number: 9405B GlaxoSmithKline PLC 15 January 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr D E Troy b) Position/status SVP & General Counsel c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant...

Director/PDMR Shareholding

RNS Number: 9402B GlaxoSmithKline PLC 15 January 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr D S Redfern b) Position/status Chief Strategy Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participan...

Director/PDMR Shareholding

RNS Number: 9373B GlaxoSmithKline PLC 15 January 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participa...

Fundamental DataMore

P/E ratio71.979
EPS18.8
Dividend yield5.912 %

Latest discussion posts More

  • Re: Broker forecasts

    Per the HL website, in January 3 brokers are saying buy and 2 hold, whereas in December it was 2 hold and 1 underweight, so they have just turned a bit more bullish. In my ...
    18-Jan-2018
    old_punter
  • Re: Broker forecasts

    I like to look at brokers views (as well as the amount the stock is being shorted). Big however. Having bought into GSK and showing a healthy profit - thus the brokers seem to ...
    17-Jan-2018
    Guemes
  • Broker forecasts

    17 Jan 18 Barclays Capital Overweight 1,366.60 1450.00 1650.00 Upgrades 16 Jan 18 Jefferies International Buy 1,366.60 - 1500.00 Reiterates 16 Jan 18 Exane BNP ...
    17-Jan-2018
    IOMINVESTCOM

Users' HoldingsMore

Users who hold Glaxosmithkline also hold..
BP50%
STAND.CHART.37%
SAINSBURY(J)25%
3I INF. ORD25%
TESCO25%

Codes & Symbols

ISINGB0009252882
SymbolsGSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account